Related content

Mycophenolate mofetil for non-renal manifestations of systemic lupus erythematosus: a systematic review

By Mok C. C.  

Scandinavian Journal of Rheumatology, Vol. 36, Iss. 5, 2007-01 ,pp. : 329-337

Informa Healthcare

Access to resources Recommend Favorite

Association of antiphospholipid antibodies with valvulopathy in systemic lupus erythematosus: a systematic review

By Mattos Priscila   Santiago Mittermayer  

Clinical Rheumatology, Vol. 30, Iss. 2, 2011-02 ,pp. : 165-171

Springer Publishing Company

Access to resources Recommend Favorite

A case of Evans syndrome combined with systemic lupus erythematosus successfully treated with rituximab

By Kittaka K.   Dobashi H.   Baba N.   Iseki K.   Kameda T.   Susaki K.   Kitanaka A.   Kubota Y.   Ishida T.  

Scandinavian Journal of Rheumatology, Vol. 37, Iss. 5, 2008-01 ,pp. : 390-393

Informa Healthcare

Access to resources Recommend Favorite

A multicenter phase I/II trial of rituximab for refractory systemic lupus erythematosus

By Tanaka Yoshiya   Yamamoto Kazuhiko   Takeuchi Tsutomu   Nishimoto Norihiro   Miyasaka Nobuyuki   Sumida Takayuki   Shima Yoshihito   Takada Kazuki   Matsumoto Isao   Saito Kazuyoshi   Koike Takao  

Modern Rheumatology, Vol. 17, Iss. 3, 2007-06 ,pp. : 191-197

Springer Publishing Company

Access to resources Recommend Favorite

Malignancies in systemic lupus erythematosus

By Kale Mruganka   Ramsey-Goldman Rosalind   Gordon Caroline   Clarke Ann E   Bernatsky Sasha  

International Journal of Clinical Rheumatology, Vol. 8, Iss. 2, 2013-04 ,pp. : 275-280

Future Medicine

Access to resources Recommend Favorite